James Storhoff
Overview
Explore the profile of James Storhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
682
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sebestyen E, Nagy A, Marosvari D, Rajnai H, Kajtar B, Deak B, et al.
J Mol Diagn
. 2021 Dec;
24(3):224-240.
PMID: 34954119
Central nervous system (CNS) lymphoma is a rare and aggressive non-Hodgkin lymphoma that might arise in the CNS (primary CNS lymphoma) or disseminates from a systemic lymphoma to the CNS...
2.
Bodor C, Alpar D, Marosvari D, Galik B, Rajnai H, Batai B, et al.
J Neuropathol Exp Neurol
. 2019 Dec;
79(2):176-183.
PMID: 31886867
Primary central nervous system lymphomas (PCNSL) are aggressive non-Hodgkin lymphomas affecting the central nervous system (CNS). Although immunophenotyping studies suggested an uniform activated B-cell (ABC) origin, more recently a spectrum...
3.
Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, et al.
BMC Med Genomics
. 2015 Aug;
8:54.
PMID: 26297356
Background: The four intrinsic subtypes of breast cancer, defined by differential expression of 50 genes (PAM50), have been shown to be predictive of risk of recurrence and benefit of hormonal...
4.
Nielsen T, Wallden B, Schaper C, Ferree S, Liu S, Gao D, et al.
BMC Cancer
. 2014 Mar;
14:177.
PMID: 24625003
Background: NanoString's Prosigna™ Breast Cancer Prognostic Gene Signature Assay is based on the PAM50 gene expression signature. The test outputs a risk of recurrence (ROR) score, risk category, and intrinsic...
5.
Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier A, Cowens J, et al.
J Clin Oncol
. 2013 Jul;
31(22):2783-90.
PMID: 23816962
Purpose: Risk of distant recurrence (DR) among women with estrogen receptor (ER) -positive early breast cancer is the major determinant of recommendations for or against chemotherapy. It is frequently estimated...
6.
Zhao J, Tang S, Storhoff J, Marla S, Bao Y, Wang X, et al.
BMC Biotechnol
. 2010 Oct;
10:74.
PMID: 20942949
Background: For more than a decade there has been increasing interest in the use of nanotechnology and microarray platforms for diagnostic applications. In this report, we describe a rapid and...